Last reviewed · How we verify

NCT07461350: SPISE

Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV

Not yet recruiting Last updated 10 March 2026
What this trial tests

trial in HIV (Human Immunodeficiency Virus) in 400 participants. Not yet recruiting.

Timeline
15 March 2026
Primary endpoint
31 March 2030
31 March 2030

Quick facts

Lead sponsorUniversity of California, San Francisco
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment400
Start date15 March 2026
Primary completion31 March 2030
Estimated completion31 March 2030
Sites4 locations across United States

Conditions studied

Sponsor

University of California, San Francisco

Who can join

30 and older, any sex, with HIV (Human Immunodeficiency Virus). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational research study is studying how substance use impacts scarring and inflammation of the heart. This study involves one study visit for a cardiac MRI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for HIV (Human Immunodeficiency Virus)

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07461350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing